Revenue and Segment Information (Tables)

12 Months Ended

Dec. 31, 2024

Revenue and Segment Information [Abstract]

Schedule of Changes in Accounts Receivable

The following tables present changes in the Company’s accounts receivable for the years ended December 31, 2024 and 2023:

	Balance as of December 31, 2023		Additions		Deductions			Balance as of December 31, 2024
Accounts receivable	$	216,504	$	4,144,226	$	(3,653,805	)	$	706,925

	Balance as of October 31, 2023		Additions		Deductions			Balance as of December 31, 2023
Accounts receivable	$	460,165	$	433,026	$	(676,687	)	$	216,504

Schedule of Information from the Consolidated Statements of Operations and Comprehensive Loss

Select information from the consolidated statements of operations and comprehensive loss as of the years ended December 31, 2024 and 2023 is as follows:

	Revenues				Net Loss Before Allocation to Noncontrolling Interest
	Year Ended December 31,				Year Ended December 31,
Segment	2024		2023		2024			2023
Specialist isotopes and related services	$	3,944,226	$	433,026	$	(21,367,787	)	$	(16,145,339	)
Nuclear fuels		200,000		—		(10,881,084	)		—
Corporate		—		—		(173,857	)		(148,787	)
	$	4,144,226	$	433,026	$	(32,422,728	)	$	(16,294,126	)

Schedule of Reconciliation of Total Segment Revenue to Total Consolidated Revenue and of Total Segment Gross Profit and Segment Operating Income to Total Consolidated Income Before Income Taxes

A reconciliation of total segment revenue to total consolidated revenue and of total segment gross profit and segment operating income to total consolidated income before income taxes, for the years ended December 31, 2024 and 2023, is as follows:

	Year Ended December 31, 2024
	Specialist isotopes and related services			Nuclear fuels			Corporate			Total
Sales from external customers	$	3,944,226		$	—		$	—		$	3,944,226
Collaboration revenue		—			200,000			—			200,000
Less: cost of sales		(2,544,614	)		—			—			(2,544,614	)
Segment gross profit		1,399,612			200,000			—			1,599,612
Personnel expenses		12,392,833			1,197,515			—			13,590,348
Professional fees		6,108,271			1,631,772			—			7,740,043
Other segment expenses		4,794,818			1,828,057			—			6,622,875
Segment operating loss		(21,896,310	)		(4,457,344	)		—			(26,353,654	)
Foreign exchange transaction gain		—			—			69,865			69,865
Change in fair value of share liability		—			—			(132,273	)		(132,273	)
Change in fair value of convertible notes payable		—			(6,875,041	)		—			(6,875,041	)
Interest income (expense), net		528,523			451,301			—			979,824
Loss before income tax expense	$	(21,367,787	)	$	(10,881,084	)	$	(62,408	)	$	(32,311,279	)

	Year Ended December 31, 2023
	Specialist isotopes and related services			Nuclear fuels		Corporate			Total
Sales from external customers	$	433,026		$	—	$	—		$	433,026
Less: cost of sales		(294,056	)		—		—			(294,056	)
Segment gross profit		138,970			—		—			138,970
Personnel expenses		11,134,296			—		—			11,134,296
Professional fees		2,994,611			—		—			2,994,611
Other segment expenses		2,052,062			—		—			2,052,062
Segment operating loss		(16,041,999	)		—		—			(16,041,999	)
Foreign exchange transaction gain		—			—		45,753			45,753
Change in fair value of share liability		—			—		(194,540	)		(194,540	)
Interest income (expense), net		(109,473	)		—		—			(109,473	)
Loss before income tax expense	$	(16,151,472	)	$	—	$	(148,787	)	$	(16,300,259	)